Schade DS - Search Results

1

Is the masked continuous glucose monitoring system clinically useful for predicting hemoglobin A1C in type 1 diabetes?

Duran-Valdez E, Burge MR, Broderick P, Shey L, Valentine V, Schrader R, Schade DS. Duran-Valdez E, et al. Among authors: schade ds. Diabetes Technol Ther. 2014 May;16(5):292-7. doi: 10.1089/dia.2013.0297. Diabetes Technol Ther. 2014. PMID: 24758730 Free PMC article.

2

Surgery and diabetes.

Schade DS. Schade DS. Med Clin North Am. 1988 Nov;72(6):1531-43. doi: 10.1016/s0025-7125(16)30720-9. Med Clin North Am. 1988. PMID: 3054366 Review.

3

Brittle diabetes: strategies, diagnosis, and treatment.

Schade DS. Schade DS. Diabetes Metab Rev. 1988 Jun;4(4):371-90. doi: 10.1002/dmr.5610040405. Diabetes Metab Rev. 1988. PMID: 3292175 Review. No abstract available.

4

Brittle diabetes: etiology and treatment.

Schade DS, Burge MR. Schade DS, et al. Adv Endocrinol Metab. 1995;6:289-319. Adv Endocrinol Metab. 1995. PMID: 7671100 Review.

5

Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency.

Burge MR, Hardy KJ, Schade DS. Burge MR, et al. Among authors: schade ds. J Clin Endocrinol Metab. 1993 May;76(5):1192-8. doi: 10.1210/jcem.76.5.8496310. J Clin Endocrinol Metab. 1993. PMID: 8496310

6

Diabetes mellitus: 1. Improving control in type I disease.

Burge MR, Schade DS. Burge MR, et al. Among authors: schade ds. Hosp Pract (1995). 1996 Nov 15;31(11):81-90 passim; discussion 102, 105. doi: 10.1080/21548331.1996.11443380. Hosp Pract (1995). 1996. PMID: 8941162

7

Diabetes mellitus: 2. Managing type II disease.

Burge MR, Schade DS. Burge MR, et al. Among authors: schade ds. Hosp Pract (1995). 1996 Dec 15;31(12):51-2, 55-60, 63-6. doi: 10.1080/21548331.1996.11443390. Hosp Pract (1995). 1996. PMID: 8969679

8

Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.

Burge MR, Waters DL, Holcombe JH, Schade DS. Burge MR, et al. Among authors: schade ds. J Clin Endocrinol Metab. 1997 Mar;82(3):920-4. doi: 10.1210/jcem.82.3.3808. J Clin Endocrinol Metab. 1997. PMID: 9062507 Clinical Trial.

9

Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.

Burge MR, Castillo KR, Schade DS. Burge MR, et al. Among authors: schade ds. Diabetes Care. 1997 Feb;20(2):152-5. doi: 10.2337/diacare.20.2.152. Diabetes Care. 1997. PMID: 9118763 Clinical Trial.

10

Insulins.

Burge MR, Schade DS. Burge MR, et al. Among authors: schade ds. Endocrinol Metab Clin North Am. 1997 Sep;26(3):575-98. doi: 10.1016/s0889-8529(05)70268-1. Endocrinol Metab Clin North Am. 1997. PMID: 9314016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page